Blueprint Medicines Corp (BPMC)

Shares of Blueprint Medicines (BPMC) were down more than 15.34% to $54.30 on Wednesday after the healthcare company announced second-quarter earnings. While the numbers were generally positive, investors are likely to sell on good news, taking advantage of a positive announcement, but the selling got out of hand.

https://www.fool.com/investing/2023/08/02/why-shares-of-blueprint-medicines-are-falling-wedn/